Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 1/20 | 0.51 |
| ▸ | GSTM2 | P28161 | 1/20 | 0.49 |
| ▸ | GRK6 | P43250 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 7/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | MYC | P01106 | 4/20 | 0.46 |
| ▸ | IDO1 | P14902 | 3/20 | 0.46 |
| ▸ | HK1 | P19367 | 1/20 | 0.45 |
| ▸ | HK2 | P52789 | 1/20 | 0.45 |
| ▸ | MAX | P61244 | 1/20 | 0.44 |
| ▸ | MIF | P14174 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34510 | 1.00 | SLC5A2 (0.51) | SLC5A2GSTM2GRK6MEN1KMT2A | |
| SCHEMBL14639838 | 1.00 | SLC5A2 (0.51) | SLC5A2GSTM2GRK6MEN1KMT2A | |
| SCHEMBL15763297 | 1.00 | SLC5A2 (0.51) | SLC5A2GSTM2GRK6MEN1KMT2A | |
| SCHEMBL15494585 | 1.00 | SLC5A2 (0.51) | SLC5A2GSTM2GRK6MEN1KMT2A | |
| SCHEMBL29402554 | 1.00 | SLC5A2 (0.51) | SLC5A2GSTM2GRK6MEN1KMT2A | |
| SCHEMBL15765529 | 1.00 | SLC5A2 (0.51) | SLC5A2GSTM2GRK6MEN1KMT2A | |
| SCHEMBL14440339 | 1.00 | SLC5A2 (0.51) | SLC5A2GSTM2GRK6MEN1KMT2A | |
| SCHEMBL12417485 | 1.00 | SLC5A2 (0.51) | SLC5A2GSTM2GRK6MEN1KMT2A | |
| SCHEMBL15763307 | 1.00 | SLC5A2 (0.51) | SLC5A2GSTM2GRK6MEN1KMT2A | |
| SCHEMBL15763313 | 1.00 | SLC5A2 (0.51) | SLC5A2GSTM2GRK6MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110189708-A1 | METHOD FOR EVALUATING SPECIFIC INCORPORATION OF D-GLUCOSE INTO CELLS | HIROSAKI UNIVERSITY (JP) | 2011-08-04 | — | — | US | disclosed |
| EP-2325327-A1 | METHOD FOR EVALUATING SPECIFIC INCORPORATION OF D-GLUCOSE INTO CELLS | Hirosaki University (JP) | 2011-05-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110189708-A1 | METHOD FOR EVALUATING SPECIFIC INCORPORATION OF D-GLUCOSE INTO CELLS | SLC2A4, SLC2A3, SLC2A1 | SLC5A2 6/4885GSTM2 3605/4885GRK6 2765/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.